Modified HS‐LASI score after 3 months · participants with hidradenitis suppurativa
1 finding from 1 review
Modified HS‐LASI score after 3 months ‐ axilla · participants with hidradenitis suppurativa
1 finding from 1 review
Modified HS‐LASI score after 3 months ‐ groin · participants with hidradenitis suppurativa
1 finding from 1 review
Modified HS‐LASI score after 3 months ‐ inframammary · participants with hidradenitis suppurativa
1 finding from 1 review
no estimate extracted
1 study · 8 participants
Very low
Percentage change in modified HS‐LASI score after 5 months compared with baseline · participants with hidradenitis suppurativa
1 finding from 1 review
Percentage change in modified HS‐LASI score after 5 months compared with baseline ‐ axilla · participants with hidradenitis suppurativa
1 finding from 1 review
Percentage change in modified HS‐LASI score after 5 months compared with baseline ‐ groin · participants with hidradenitis suppurativa
1 finding from 1 review
Complete cure ‐ not measured · People with fungal infections of the toenails
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (collected over the course of the studies; they are not measured/reported for specific time points) · People with fungal infections of the toenails
It is very uncertain whether 1064‐nm Nd:YAG laser changes adverse events (collected over the course of the studies; they are… compared with no treatment or sham treatment (very low certainty).
1 finding from 1 review
Mycological cure · People with fungal infections of the toenails
1064‐nm Nd:YAG laser showed no clear difference in mycological cure: 52 weeks compared with no treatment or sham treatment (low certainty).
1 finding from 1 review
Clinical cure ‐ not measured · People with fungal infections of the toenails
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
Proportion of participants with adverse event1 Pain as assessed by VAS (0 to 10; higher score is worse) · Participants with rosacea
1 finding from 1 review
Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Assessment of erythema or telangiectasia1 Spectrophotometer to assess facial redness · Participants with rosacea
1 finding from 1 review
Lesion count ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Time needed until improvement ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review